Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;15(11):415.
doi: 10.1007/s11920-013-0415-y.

Pharmacotherapy for stimulant-related disorders

Colin N Haile  1 , Thomas R Kosten
Affiliations
Review

Pharmacotherapy for stimulant-related disorders

Colin N Haile et al. Curr Psychiatry Rep. 2013 Nov.

Abstract

Stimulant-related disorders (SRD) continue to be an important public health problem for which there are presently no approved pharmacotherapies. Although behavioral interventions provide some benefit response varies. The development of novel and effective pharmacotherapies continues to be a research priority. Understanding neural mechanisms critical to the action of stimulants has helped reveal several potential pharmacotherapies that have already shown promise in controlled clinical trials. Common to some of these medications is the ability to reverse neural deficits in individuals with SRD. Results from thoroughly conducted clinical trials continue to broaden our knowledge increasing the possibility of soon developing effective pharmacotherapies for SRD.

PubMed Disclaimer

References

    1. SAMHSA . Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. 2013. Substance Abuse and Mental Health Services Administration; Rockville, MD: - PubMed
    1. Haile CN, et al. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther. 2012;134(2):260–77. - PMC - PubMed
    1. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652–69. - PMC - PubMed
    1. Sofuoglu M, et al. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology. 2013;64:452–63. - PMC - PubMed
    1. Weinshenker D, Schroeder JP. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology. 2007;32(7):1433–51. - PubMed

Publication types

MeSH terms

Substances